CN Stock MarketDetailed Quotes

Tiansheng Pharmaceutical Group (002872)

Watchlist

5.49
0.000.00%

Trading Mar 9 10:40 CST

1.75BMarket Cap-18.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tiansheng Pharmaceutical Group (002872) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

Self-made oral solid preparation104.9M45.18%

Self-made small volume injection54.3M23.38%

Homemade large volume injection43.32M18.66%

Other business15.01M6.46%

Homemade other varieties7.54M3.25%

Outsourcing variety7.13M3.07%

View all

By Industry

Currency:CNY

2025/H1

Stock NameRevenueRatio

Pharmaceutical manufacturing210.06M90.47%

Other business15.01M6.46%

Pharmaceutical circulation7.13M3.07%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

Southwest area112.9M48.62%

East China region38.07M16.40%

South China30.34M13.07%

Central China28.79M12.40%

Northwest region9.63M4.15%

North China9.56M4.12%

Northeast area2.9M1.25%

View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol % Chg